ASTHAVENT

This brand name is authorized in Nigeria. It is also authorized in South Africa.

Active ingredients

The drug ASTHAVENT contains one active pharmaceutical ingredient (API):

1
UNII 021SEF3731 - ALBUTEROL SULFATE
 

Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases.

 
Read more about Salbutamol

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A11-100642 Syrup ASTHAVENT SYRUP SYRUP 2 mg/5 mL 36 NF-PP-239645 ASTHAVENT SYRUP SALBUTAMOL SYRUP (2mg/5ml ) Each 5ml contains: Salbutamol Sulphate 2.41mg, Sodium Citrate 7.50mg, Citric Acid Monohydrate 15mg, Sodium Benzoate 5mg, Sodium Saccharin 2.5mg, Glycerin 1400mg, Banana Flavour 2.5mg, Purified Water …qs… 5ml. A11-100642 Drugs Nigerian Products 100ML POM 1 11/20/2021 UNIQUE PHARMACEUTICALS LIMITED, KM 38, ABEOKUTA ROAD, VEEPEE INDUSTRIAL AVENUE, SANGO-OTA,OGUN STATE. 8097421000 mail@uniquepharm.com UNIQUE PHARMACEUTICALS LIMITED, 11, FATAI ATERE WAY, MATORI, MUSHIN, LAGOS., Nigeria 31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03AC02 Salbutamol R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC02
R03CC02 Salbutamol R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03CC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A11-100642
ZA Health Products Regulatory Authority 30/10.2.1/0119, 30/10.2.1/0345, 30/10.2.2/0200, 34/10.2.1/0354, A39/10.2.1/0482

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.